{"disease":{"id":"tauopathies","name":"tauopathies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06596746","title":"Neurodegenerative Diseases Progression Markers (MARKERS-NDD)","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Casa di Cura San Raffaele Cassino","has_results":false},{"nct_id":"NCT06690983","title":"Tau PET/CT in Various Tau-Related Disease Patients","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Tianjin Medical University","has_results":false},{"nct_id":"NCT05427448","title":"Validation of Blood Biomarkers for Alzheimer's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":342,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT05318976","title":"A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":208,"lead_sponsor_name":"Inmune Bio, Inc.","has_results":false},{"nct_id":"NCT03538522","title":"A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":126,"lead_sponsor_name":"Biomed Industries, Inc.","has_results":false},{"nct_id":"NCT03938870","title":"CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease","phase":"","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT06083467","title":"CW2IP2: Imaging and Diagnostic Assessments","phase":"NA","overall_status":"RECRUITING","enrollment_count":94,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT05202223","title":"Harmony at Home: A Pilot Telehealth Program for Rural ADRD Caregivers","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Elizabeth K Rhodus","has_results":true},{"nct_id":"NCT05080777","title":"Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems","phase":"NA","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"UConn Health","has_results":true},{"nct_id":"NCT06032026","title":"Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT02294851","title":"A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of Intravenously Administered BMS-986168 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT04445831","title":"A Study to Evaluate the Safety, Tolerability and Immunogenicity of Tau Targeted Vaccines in Participants With Early Alzheimer's Disease","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"AC Immune SA","has_results":true},{"nct_id":"NCT05527288","title":"A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Sinotau Pharmaceutical Group","has_results":false},{"nct_id":"NCT03658135","title":"BIIB092 in Primary Tauopathies: CBS, nfvPPA, sMAPT, and TES","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":22,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT07306598","title":"[18F]NIDF PET Imaging in Tau-related Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Tianjin Medical University","has_results":false},{"nct_id":"NCT05522387","title":"An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"Inmune Bio, Inc.","has_results":false}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}